Deepening Accountability: The Fair Pharma Scorecard and Access to Medicines in a Fragmented Global Health Law Landscape
On the occasion of Human Rights Day, the Pharmaceutical Accountability Foundation is pleased to announce a new publication in the Journal of Health and Human Rights. Authored by Rosalind Turkie, a human rights lawyer, and Dr Pramiti Parwani, a health and intellectual property specialist, the paper explores gaps in who can be held accountable for ensuring access to medicines as a crucial part of the human right to health. In particular, legal systems often do not have means to take into account the role of pharmaceutical companies and their duty of care to ensure that states have the capacity to ensure access to medicines. It then introduces the Fair Pharma Scorecard – Cancer Edition as an innovative tool to close these gaps by evaluating the extent to which pharmaceutical companies who own patents on leading cancer medications comply with a range of principles drawn from human rights law, soft-law, and ethics in medical research.
The PDF of the article can be downloaded here: https://www.pharmaceuticalaccountability.org/wp-content/uploads/2025/12/turkie_acc.pdf
The methodology in this paper will be used to research and produce a Fair Pharma Scorecard – Cancer edition in 2026.
Wilbert Bannenberg